Biomarkers of bone health and osteoporosis risk (Q37138648)

18 August 2017

1 reference

title

Biomarkers of bone health and osteoporosis risk (English)

1 reference

18 August 2017

0 references

0 references

Richard Eastell

1 reference

18 August 2017

Rosemary A Hannon

1 reference

18 August 2017

publication date

1 May 2008

1 reference

Proceedings of the Nutrition Society

18 August 2017

published in

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

18 August 2017

page(s)

157-162

1 reference

Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

The contribution of bone loss to postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Bone quality--the material and structural basis of bone strength and fragility

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Epidemiology and outcomes of osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Biochemical markers for prediction of 4-year response in bone mass during bisphosphonate treatment for prevention of postmenopausal osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: a three-year, double-blind, placebo-controlled,

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Age and menopause-related changes in indices of bone turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Serum levels of cathepsin K decrease with age in both women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Relationship of bone turnover to bone density and fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Effect of the menopause and hormone replacement therapy on the carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Biochemical markers of bone turnover and fracture prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Biochemical markers of bone turnover reflect femoral bone loss in elderly women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Can urinary pyridinium crosslinks and urinary oestrogens predict bone mass and rate of bone loss after the menopause?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Urinary N-telopeptides to monitor bone resorption while on GnRH agonist therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

7 January 2021

High bone turnover is associated with low bone mass in both pre- and postmenopausal women

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

7 January 2021

Do Markers of Bone Resorption Add to Bone Mineral Density and Ultrasonographic Heel Measurement for the Prediction of Hip Fracture in Elderly Women? The EPIDOS Prospective Study

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

7 January 2021

Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

7 January 2021

Bone resorption in healthy and osteoporotic postmenopausal women: comparison markers for serum carboxy-terminal telopeptide of type I collagen and urinary pyridinium cross-links

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

7 January 2021

Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

7 January 2021

Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

7 January 2021

A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

7 January 2021

Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

7 January 2021

Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

7 January 2021

Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

7 January 2021

Biochemical markers as predictors of rates of bone loss after menopause

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

7 January 2021

Biochemical markers of bone metabolism and prediction of fracture in elderly women.

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

7 January 2021

Bone density change and biochemical indices of skeletal turnover

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

7 January 2021

Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

7 January 2021

Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

7 January 2021

Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover

1 reference

https://api.crossref.org/works/10.1017%2FS002966510800699X

7 January 2021

10.1017/S002966510800699X

Identifiers

DOI

1 reference

18 August 2017

1 reference